Detalle Publicación

When Cancer Vaccines Go Viral

Título de la revista: CLINICAL CANCER RESEARCH
ISSN: 1078-0432
Volumen: 25
Número: 16
Páginas: 4871 - 4873
Fecha de publicación: 2019
Induction of antitumor responses by vaccines requires strong immunogens. Heterologous viral prime/boost immunization with the BN-CV301 vaccine promotes activation of immune responses that provide a clinical benefit to patients with cancer. This viral platform may be used to harbor different antigens and prime tumor immunity potentially useful for combinatorial strategies.